GSK Recall: FDA Investigates Weight Loss Drug Tampering

GSK launched an investigation with the FDA for its over-the-counter weight-loss drug Alli on Wednesday, after consumers reported that some bottles contained products other than the drug.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news